MDMaria Rosaria Domenici

Maria Rosaria Domenici

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Rosaria Domenici has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of the STriatal Enriched Tyrosine Phosphatase ( STEP ) Inhibitor TC ‐2153 on Hippocampal Long‐Term Depression and Synaptic Transmission: Paradoxical Effect on Phosphatase Activity and Role of Adenosine

    by Valentina Chiodi, Rita Pepponi, Lucia Gaddini, Zaira Boussadia, Emilia Marchei, Manuela Pellegrini, Cinzia Mallozzi, Maria Rosaria Domenici

    Aims: This study aimed to explore the effects of TC‐2153, the STriatal Enriched Tyrosine Phosphatase (STEP) inhibitor, on Long‐Term Depression (LTD) and basal synaptic transmission in hippocampal slices. Methods: Extracellular field potentials were recorded in the CA1 area of the hippocampal slices. LTD was induced by low‐frequency stimulation and by metabotropic glutamate receptor stimulation. The activity of STEP was measured in hippocampal slices and in SH‐SY5Y cell culture by a colorimetric assay using p‐nitrophenol as a substrate. To evaluate adenosine levels, adenosine was extracted from hippocampal slices homogenates and measured by HPLC. Results: TC‐2153 3 μM, applied to the slices one hour before and then along the electrophysiological recordings, blocked both forms of LTD. When hippocampal slices were treated with TC‐2153 for shorter periods, 10–20 min, TC‐2153 reduced synaptic transmission and increased STEP activity with an adenosine A1 receptor‐dependent mechanism. Consistently, we found that TC‐2153 increased adenosine levels in hippocampal slices. The increase in STEP activity after brief TC‐2153 treatment has been confirmed in SH‐SY5Y cells. Conclusion: Our study confirms the role of STEP in LTD and reveals a new mechanism of action for TC‐2153. The unexpected adenosine‐dependent activation of STEP by TC‐2153 has significant implications for both basic research and potential therapeutic applications.

  • Open Access

    Loss of histone macroH2A1.1 causes kidney abnormalities secondary to a change in nutrient metabolization

    by René Winkler, Gemma Comas-Armangué, David Corujo, Adrián Sanz-Moreno, Julia Calzada-Wack, Shubhra Ashish Bhattacharya, Birgit Rathkolb, Nathalia Romanelli Vicente Dragano, Colina X. Qiao, Valentina Chiodi, et al.

    Histone variants with metabolite-binding macrodomains provide a poorly understood link between chromatin composition and metabolism. To address their contribution to physiological health, we generated and analyzed mice individually lacking the histone variants macroH2A1.1, macroH2A1.2, or macroH2A2. We identified several histopathologic changes in the kidney as isoform-specific phenotype of complete macroH2A1.1 loss affecting male and female animals. Kidney alterations were barely associated with organ-intrinsic gene expression changes but strongly correlated with a systemic shift in nutrient metabolization and alterations in NAD + (nicotinamide adenine dinucleotide, oxidized form) metabolism. Reduced lipid oxidation and increased glycolysis were found in male and female mice lacking macroH2A1.1 but not macroH2A1.2 or macroH2A2. Male macroH2A1.1-deficient mice also had better glucose tolerance and altered hepatic gene expression. Replacing chow by ketogenic diet overrode the macroH2A1.1-dependent metabolic phenotype and prevented kidney abnormalities. Together, our results indicate that macroH2A1.1 controls nutrient metabolization and links macroH2A1.1 levels to secondary changes in the kidney.


  • Open Access

    The DNA repair protein DNA-PKcs modulates synaptic plasticity via PSD-95 phosphorylation and stability

    by Cristiana Mollinari, Alessio Cardinale, Leonardo Lupacchini, Alberto Martire, Valentina Chiodi, Andrea Martinelli, Anna Maria Rinaldi, Massimo Fini, Simonetta Pazzaglia, Maria Rosaria Domenici, et al.

    The key DNA repair enzyme DNA-PKcs has several and important cellular functions. Loss of DNA-PKcs activity in mice has revealed essential roles in immune and nervous systems. In humans, DNA-PKcs is a critical factor for brain development and function since mutation of the prkdc gene causes severe neurological deficits such as microcephaly and seizures, predicting yet unknown roles of DNA-PKcs in neurons. Here we show that DNA-PKcs modulates synaptic plasticity. We demonstrate that DNA-PKcs localizes at synapses and phosphorylates PSD-95 at newly identified residues controlling PSD-95 protein stability. DNA-PKcs −/− mice are characterized by impaired Long-Term Potentiation (LTP), changes in neuronal morphology, and reduced levels of postsynaptic proteins. A PSD-95 mutant that is constitutively phosphorylated rescues LTP impairment when over-expressed in DNA-PKcs −/− mice. Our study identifies an emergent physiological function of DNA-PKcs in regulating neuronal plasticity, beyond genome stability.


  • Open Access

    Functional Interaction between Adenosine A2A and mGlu5 Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGlu5R Binding in Mouse Hippocampus and Neuroblastoma Cell Line

    by Cinzia Mallozzi, Rita Pepponi, Lucia Gaddini, Ida Casella, Valentina Chiodi, Patrizia Popoli, Maria Rosaria Domenici

    (1) Background: Recently, we found that adenosine A2A receptor (A2AR) stimulation results in an increase in STEP phosphatase activity. In order to delve into the mechanism through which A2AR stimulation induced STEP activation, we investigated the involvement of mGlu5R since it is well documented that A2AR and mGlu5R physically and functionally interact in several brain areas. (2) Methods: In a neuroblastoma cell line (SH-SY5Y) and in mouse hippocampal slices, we evaluated the enzymatic activity of STEP by using a para-nitrophenyl phosphate colorimetric assay. A co-immunoprecipitation assay and a Western blot analysis were used to evaluate STEP/mGlu5R binding. (3) Results: We found that the A2AR-dependent activation of STEP was mediated by the mGlu5R. Indeed, the A2AR agonist CGS 21680 significantly increased STEP activity, and this effect was prevented not only by the A2AR antagonist ZM 241385, as expected, but also by the mGlu5R antagonist MPEP. In addition, we found that mGlu5R agonist DHPG-induced STEP activation was reversed not only by the mGlu5R antagonist MPEP but also by ZM 241385. Finally, via co-immunoprecipitation experiments, we found that mGlu5R and STEP physically interact when both receptors are activated (4) Conclusions: These results demonstrated a close functional interaction between mGlu5 and A2A receptors in the modulation of STEP activity.


  • Open Access

    Insight into the Role of the STriatal-Enriched Protein Tyrosine Phosphatase (STEP) in A2A Receptor-Mediated Effects in the Central Nervous System

    by Maria Rosaria Domenici, Cinzia Mallozzi, Rita Pepponi, Ida Casella, Valentina Chiodi, Antonella Ferrante, Patrizia Popoli

    The STriatal-Enriched protein tyrosine phosphatase STEP is a brain-specific tyrosine phosphatase that plays a pivotal role in the mechanisms of learning and memory, and it has been demonstrated to be involved in several neuropsychiatric diseases. Recently, we found a functional interaction between STEP and adenosine A2A receptor (A2AR), a subtype of the adenosine receptor family widely expressed in the central nervous system, where it regulates motor behavior and cognition, and plays a role in cell survival and neurodegeneration. Specifically, we demonstrated the involvement of STEP in A2AR-mediated cocaine effects in the striatum and, more recently, we found that in the rat striatum and hippocampus, as well as in a neuroblastoma cell line, the overexpression of the A2AR, or its stimulation, results in an increase in STEP activity. In the present article we will discuss the functional implication of this interaction, trying to examine the possible mechanisms involved in this relation between STEP and A2ARs.


  • The activity of the Striatal‐enriched protein tyrosine phosphatase in neuronal cells is modulated by adenosine A2A receptor

    by Cinzia Mallozzi, Rita Pepponi, Sergio Visentin, Valentina Chiodi, Paul J. Lombroso, Michael Bader, Patrizia Popoli, Maria Rosaria Domenici

    We recently demonstrated that a tonic activation of adenosine A2A receptors (A2ARs) is required for cocaine‐induced synaptic depression and increase in the activity of STriatal‐Enriched protein tyrosine Phosphatase (STEP). In this study, we elaborated on the relationship between A2AR and STEP using genetic, pharmacological, and cellular tools. We found that the activities of protein tyrosine phosphatases (PTPs), and in particular of STEP, are significantly increased in the striatum and hippocampus of a transgenic rat strain over‐expressing the neuronal A2AR (NSEA2A) with respect to wild‐type (WT) rats. Moreover the selective A2AR agonist 4‐[2‐[[6‐Amino‐9‐(N‐ethyl‐β‐d‐ribofuranuronamidosyl)‐9H‐purin‐2‐yl]amino]ethyl]benzenepropanoic acid hydrochloride up‐regulates PTPs and STEP activities in WT but not in NSEA2A rats, while the selective A2AR antagonist 4‐(−2‐[7‐amino‐2‐{2‐furyl}{1,2,4}triazolo{2,3‐a} {1,3,5}triazin‐5‐yl‐amino]ethyl)phenol restores the tyrosine phosphatase activities in NSEA2A, having no effects in WT rats. In addition, while cocaine induced the activation of PTP and STEP in WT rats, it failed to increase phosphatase activity in NSEA2A rats. A2ARs modulate STEP activity also in the SH‐SY5Y neuroblastoma cell line, where a calcium‐dependent calcineurin/PP1 pathway was found to play a major role. In summary, the present study identified a novel interaction between A2AR and STEP that could have important clinical implications, since STEP has emerged as key regulator of signaling pathways involved in neurodegenerative and neuropsychiatric diseases and A2ARs are considered a promising target for the development of therapeutic strategies for different diseases of the central nervous system. image Read the Editorial Highlight for this article on page 270


  • Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders

    by Maria Rosaria Domenici, Antonella Ferrante, Alberto Martire, Valentina Chiodi, Rita Pepponi, Maria Teresa Tebano, Patrizia Popoli


  • Open Access

    Activation of Phosphotyrosine-Mediated Signaling Pathways in the Cortex and Spinal Cord of SOD1G93A, a Mouse Model of Familial Amyotrophic Lateral Sclerosis

    by Cinzia Mallozzi, Alida Spalloni, Patrizia Longone, Maria Rosaria Domenici

    Degeneration of cortical and spinal motor neurons is the typical feature of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease for which a pathogenetic role for the Cu/Zn superoxide dismutase (SOD1) has been demonstrated. Mice overexpressing a mutated form of the SOD1 gene (SOD1G93A) develop a syndrome that closely resembles the human disease. The SOD1 mutations confer to this enzyme a “gain-of-function,” leading to increased production of reactive oxygen species. Several oxidants induce tyrosine phosphorylation through direct stimulation of kinases and/or phosphatases. In this study, we analyzed the activities of src and fyn tyrosine kinases and of protein tyrosine phosphatases in synaptosomal fractions prepared from the motor cortex and spinal cord of transgenic mice expressing SOD1G93A. We found that (i) protein phosphotyrosine level is increased, (ii) src and fyn activities are upregulated, and (iii) the activity of tyrosine phosphatases, including the striatal-enriched tyrosine phosphatase (STEP), is significantly decreased. Moreover, the NMDA receptor (NMDAR) subunit GluN2B tyrosine phosphorylation was upregulated in SOD1G93A. Tyrosine phosphorylation of GluN2B subunits regulates the NMDAR function and the recruitment of downstream signaling molecules. Indeed, we found that proline-rich tyrosine kinase 2 (Pyk2) and ERK1/2 kinase are upregulated in SOD1G93Amice. These results point out an involvement of tyrosine kinases and phosphatases in the pathogenesis of ALS.


  • Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington’s disease

    by Maria Rosaria Domenici, Valentina Chiodi, Mirko Averna, Monica Armida, Antonella Pèzzola, Rita Pepponi, Antonella Ferrante, Michael Bader, Kjell Fuxe, Patrizia Popoli

    The A2A adenosine receptor (A2AR) is widely distributed on different cellular types in the brain, where it exerts a broad spectrum of pathophysiological functions, and for which a role in different neurodegenerative diseases has been hypothesized or demonstrated. To investigate the role of neuronal A2ARs in neurodegeneration, we evaluated in vitro and in vivo the effect of the neurotoxin 3-nitropropionic acid (3-NP) in a transgenic rat strain overexpressing A2ARs under the control of the neural-specific enolase promoter (NSEA2A rats). We recorded extracellular field potentials (FP) in corticostriatal slice and found that the synaptotoxic effect of 3-NP was significantly reduced in NSEA2A rats compared with wild-type animals (WT). In addition, after exposing corticostriatal slices to 3-NP 10 mM for 2 h, we found that striatal cell viability was significantly higher in NSEA2A rats compared to control rats. These in vitro results were confirmed by in vivo experiments: daily treatment of female rats with 3-NP 10 mg/kg for 8 days induced a selective bilateral lesion in the striatum, which was significantly reduced in NSEA2A compared to WT rats. These results demonstrate that the overexpression of the A2AR selectively at the neuronal level reduced 3-NP-induced neurodegeneration, and suggest an important function of the neuronal A2AR in the modulation of neurodegeneration.


  • Striatal adenosine–cannabinoid receptor interactions in rats over‐expressing adenosine A2A receptors

    by Valentina Chiodi, Antonella Ferrante, Luca Ferraro, Rosa Luisa Potenza, Monica Armida, Sarah Beggiato, Antonella Pèzzola, Michael Bader, Kjell Fuxe, Patrizia Popoli, et al.

    Adenosine A2A receptors (A2ARs) and cannabinoid CB1 receptors (CB1Rs) are highly expressed in the striatum, where they functionally interact and form A2A/CB1 heteroreceptor complexes. We investigated the effects of CB1R stimulation in a transgenic rat strain over‐expressing A2ARs under the control of the neural‐specific enolase promoter (NSEA2A rats) and in age‐matched wild‐type (WT) animals. The effects of the CB1R agonist WIN 55,212‐2 (WIN) were significantly lower in NSEA2A rats than in WT animals, as demonstrated by i) electrophysiological recordings of synaptic transmission in corticostriatal slices; ii) the measurement of glutamate outflow from striatal synaptosomes and iii) in vivo experiments on locomotor activity. Moreover, while the effects of WIN were modulated by both A2AR agonist (CGS 21680) and antagonists (ZM 241385, KW‐6002 and SCH‐442416) in WT animals, the A2AR antagonists failed to influence WIN‐mediated effects in NSEA2A rats. The present results demonstrate that in rats with genetic neuronal over‐expression of A2ARs, the effects mediated by CB1R activation in the striatum are significantly reduced, suggesting a change in the stoichiometry of A2A and CB1 receptors and providing a strategy to dissect the involvement of A2AR forming or not forming heteromers in the modulation of striatal functions. These findings add additional evidence for the existence of an interaction between striatal A2ARs and CB1Rs, playing a fundamental role in the regulation of striatal functions. image We studied A2A‐CB1 receptor interaction in transgenic rats over‐expressing adenosine A2A receptors under the control of the neuron‐specific enolase promoter (NSEA2A). In these rats, we demonstrated a reduced effect of the CB1 receptor agonist WIN 55,212‐2 in the modulation of corticostriatal synaptic transmission and locomotor activity, while CB1 receptor expression level did not change with respect to WT rats. A reduction in the expression of A2A‐CB1 receptor heteromers is postulated.Read the Editorial Highlight for this article on page 897.